These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 17242032)

  • 1. Efficacy of aminocandin in the treatment of immunocompetent mice with haematogenously disseminated fluconazole-resistant candidiasis.
    Ghannoum MA; Kim HG; Long L
    J Antimicrob Chemother; 2007 Mar; 59(3):556-9. PubMed ID: 17242032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
    Warn PA; Sharp A; Morrissey G; Denning DW
    J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic and prophylactic efficacy of aminocandin (IP960) against disseminated candidiasis in mice.
    Najvar LK; Bocanegra R; Wiederhold NP; Lambros C; Najarian N; Patterson TF; Graybill JR
    Clin Microbiol Infect; 2008 Jun; 14(6):595-600. PubMed ID: 18397335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model.
    González GM; Portillo OJ; Uscanga GI; Andrade SE; Robledo M; Rodríguez C; Elizondo M
    J Antimicrob Chemother; 2009 Sep; 64(3):571-3. PubMed ID: 19570754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
    Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus.
    Warn PA; Sharp A; Morrissey G; Denning DW
    Int J Antimicrob Agents; 2010 Feb; 35(2):146-51. PubMed ID: 20015618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice.
    Khan MA; Khan A; Owais M
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):63-9. PubMed ID: 16420598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined antifungal therapy in a murine infection by Candida glabrata.
    Mariné M; Serena C; Pastor FJ; Guarro J
    J Antimicrob Chemother; 2006 Dec; 58(6):1295-8. PubMed ID: 17012301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
    Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
    J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata.
    Mariné M; Serena C; Fernández-Torres B; Pastor FJ; Guarro J
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4757-9. PubMed ID: 16251323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
    Melkusová S; Bujdáková H; Volleková A; Myoken Y; Mikami Y
    Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of micafungin against deep-seated candidiasis in cyclophosphamide-induced immunosuppressed mice.
    Ninomiya M; Mikamo H; Tanaka K; Watanabe K; Tamaya T
    J Antimicrob Chemother; 2005 Apr; 55(4):587-90. PubMed ID: 15728144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fluconazole era: management of hematogenously disseminated candidiasis in the nonneutropenic patient.
    Kramer KM; Skaar DJ; Ackerman BH
    Pharmacotherapy; 1997; 17(3):538-48. PubMed ID: 9165556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired resistance to echinocandins in Candida albicans: case report and review.
    Baixench MT; Aoun N; Desnos-Ollivier M; Garcia-Hermoso D; Bretagne S; Ramires S; Piketty C; Dannaoui E
    J Antimicrob Chemother; 2007 Jun; 59(6):1076-83. PubMed ID: 17468115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of aminocandin (HMR 3270) on the in-vitro adherence of Candida albicans to polystyrene surfaces coated with extracellular matrix proteins or fibronectin.
    Cateau E; Levasseur P; Borgonovi M; Imbert C
    Clin Microbiol Infect; 2007 Mar; 13(3):311-5. PubMed ID: 17391387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparative efficacy of cilofungin, fluconazole and amphotericin B in disseminated Candida tropicalis infection in neutropenic mice.
    Fong IW; Bannatyne RM; Cheng PC
    Clin Invest Med; 1992 Oct; 15(5):434-9. PubMed ID: 1458716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients.
    de Wet N; Llanos-Cuentas A; Suleiman J; Baraldi E; Krantz EF; Della Negra M; Diekmann-Berndt H
    Clin Infect Dis; 2004 Sep; 39(6):842-9. PubMed ID: 15472817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic and gastrointestinal candidiasis of infant mice as model for antifungal therapy.
    Ponnuvel KM; Rama CP; Menon T
    Indian J Exp Biol; 1993 May; 31(5):450-2. PubMed ID: 8359853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascorbic acid decreases the antifungal effect of fluconazole in the treatment of candidiasis.
    Wang Y; Jia XM; Jia JH; Li MB; Cao YY; Gao PH; Liao WQ; Cao YB; Jiang YY
    Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):e40-6. PubMed ID: 19413603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility.
    Brzankalski GE; Najvar LK; Wiederhold NP; Bocanegra R; Fothergill AW; Rinaldi MG; Pattterson TF; Graybill JR
    J Antimicrob Chemother; 2008 Nov; 62(5):1094-100. PubMed ID: 18658194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.